Filing Flows › Verastem (VSTM) › Q3 2026
Verastem (VSTM) Q3 2026 earnings results (third quarter 2026)
10-Q filed Nov 5, 2026
Verastem (VSTM) reported revenue of $24.0M for the third quarter 2026 (Q3 2026), +114% from a year earlier and -40% from the quarter before. Operating margin was -313.3%, net loss $74.7M (311.2% of revenue).
Verastem, Q3 2026: revenue $24.0M (+114% year over year), operating margin -313.3%, net loss $74.7M, operating cash flow −$33.6M. The chart follows the revenue to costs, profit and cash.
| Q3 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $24.0M | -40% | +114% |
| Operating profit | −$75.2M | — | — |
| Net earnings | −$74.7M | — | — |
| Operating cash flow | −$33.6M | — | — |
What changed
Revenue was $24.0M in Q3 2026, up 114% year over year and down 40% from the previous quarter.
Operating costs exceeded revenue by $75.2M, an operating margin of -313.3%. Total costs grew 91% against revenue growth of 114%. The fastest-growing cost line was Research & development (+137%). The quarter ended with a net loss of $74.7M, wider than the previous quarter's $34.7M loss.
Operating cash flow was −$33.6M. Non-cash charges added back $3.7M of share-based compensation. Working capital and other items added $37.4M.
Questions
What was Verastem's revenue in the third quarter 2026?
Verastem (VSTM) reported revenue of $24.0M for the third quarter 2026 (Q3 2026), +114% from a year earlier and -40% from the quarter before.
Was Verastem profitable in the third quarter 2026?
Operating loss was $75.2M (-313.3% of revenue) and net loss $74.7M.
Source: Verastem 10-Q on SEC EDGAR.